Annual Decline in Pentraxin 3 Is a Risk of Vascular Access Troubles in Hemodialysis Patients
Pentraxin 3 (PTX3), a multifunctional modulator of the innate immunoinflammatory response, is higher in patients undergoing hemodialysis than healthy control. Our study focused on annual change in PTX3 levels in patients with chronic hemodialysis, because regularly undergoing hemodialysis for many y...
Saved in:
Main Authors: | Kei Nagai, Atsushi Ueda, Chie Saito, Asako Zempo-Miyaki, Kunihiro Yamagata |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | International Journal of Nephrology |
Online Access: | http://dx.doi.org/10.1155/2014/297954 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frailty and outcomes of vascular access for hemodialysis – a scoping review
by: Lara R. Dias, et al.
Published: (2025-01-01) -
Vascular access on YouTube: Navigating the stream of information for hemodialysis patients
by: Alp Yildirim, et al.
Published: (2024-03-01) -
The Initial Vascular Access Type Contributes to Inflammation in Incident Hemodialysis Patients
by: Mala Sachdeva, et al.
Published: (2012-01-01) -
Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
by: Shingo Hatakeyama, et al.
Published: (2011-01-01) -
Is There Gender Disparity in Vascular Access for Hemodialysis with New Percutaneous Systems? A Systematic Review
by: Hugo Vergara-Pérez, et al.
Published: (2024-09-01)